Insufficient scRNA-seq data for expression of NOG at single-cell level.
Insufficient scRNA-seq data for expression of NOG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 205.95 | 2447 / 2642 | 98% | 25.87 | 690 / 705 |
lung | 86% | 69.83 | 497 / 578 | 41% | 1.75 | 470 / 1155 |
thymus | 69% | 38.32 | 453 / 653 | 53% | 2.07 | 321 / 605 |
prostate | 80% | 77.35 | 197 / 245 | 29% | 0.49 | 147 / 502 |
kidney | 61% | 32.22 | 54 / 89 | 38% | 3.19 | 344 / 901 |
muscle | 96% | 173.77 | 767 / 803 | 0% | 0 | 0 / 0 |
bladder | 76% | 70.67 | 16 / 21 | 17% | 1.87 | 87 / 504 |
blood vessel | 85% | 96.35 | 1138 / 1335 | 0% | 0 | 0 / 0 |
stomach | 61% | 66.14 | 220 / 359 | 21% | 0.74 | 60 / 286 |
pancreas | 2% | 0.90 | 7 / 328 | 75% | 3.66 | 133 / 178 |
esophagus | 59% | 50.22 | 858 / 1445 | 17% | 0.43 | 31 / 183 |
ovary | 8% | 3.44 | 15 / 180 | 60% | 3.44 | 259 / 430 |
skin | 54% | 69.61 | 973 / 1809 | 14% | 1.73 | 66 / 472 |
breast | 49% | 26.10 | 226 / 459 | 17% | 0.67 | 191 / 1118 |
uterus | 29% | 49.00 | 49 / 170 | 31% | 2.75 | 144 / 459 |
intestine | 40% | 23.37 | 388 / 966 | 12% | 0.38 | 64 / 527 |
adipose | 48% | 38.61 | 582 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 2.79 | 19 / 258 | 30% | 5.27 | 68 / 230 |
peripheral blood | 27% | 17.10 | 252 / 929 | 0% | 0 | 0 / 0 |
spleen | 24% | 12.11 | 59 / 241 | 0% | 0 | 0 / 0 |
heart | 24% | 14.15 | 209 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.56 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 7.09 | 8 / 45 |
liver | 4% | 2.35 | 10 / 226 | 3% | 0.15 | 11 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0001839 | Biological process | neural plate morphogenesis |
GO_0061384 | Biological process | heart trabecula morphogenesis |
GO_1904888 | Biological process | cranial skeletal system development |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0007224 | Biological process | smoothened signaling pathway |
GO_0035640 | Biological process | exploration behavior |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0055009 | Biological process | atrial cardiac muscle tissue morphogenesis |
GO_0060392 | Biological process | negative regulation of SMAD protein signal transduction |
GO_0001701 | Biological process | in utero embryonic development |
GO_0003272 | Biological process | endocardial cushion formation |
GO_0021510 | Biological process | spinal cord development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0090193 | Biological process | positive regulation of glomerulus development |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0061053 | Biological process | somite development |
GO_0060044 | Biological process | negative regulation of cardiac muscle cell proliferation |
GO_0060173 | Biological process | limb development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0060513 | Biological process | prostatic bud formation |
GO_0003149 | Biological process | membranous septum morphogenesis |
GO_0060302 | Biological process | negative regulation of cytokine activity |
GO_1990926 | Biological process | short-term synaptic potentiation |
GO_0003223 | Biological process | ventricular compact myocardium morphogenesis |
GO_0048570 | Biological process | notochord morphogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0048712 | Biological process | negative regulation of astrocyte differentiation |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0060676 | Biological process | ureteric bud formation |
GO_0008542 | Biological process | visual learning |
GO_0060272 | Biological process | embryonic skeletal joint morphogenesis |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0042060 | Biological process | wound healing |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0021533 | Biological process | cell differentiation in hindbrain |
GO_0048168 | Biological process | regulation of neuronal synaptic plasticity |
GO_0001707 | Biological process | mesoderm formation |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0060425 | Biological process | lung morphogenesis |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0001843 | Biological process | neural tube closure |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0038092 | Biological process | nodal signaling pathway |
GO_0090190 | Biological process | positive regulation of branching involved in ureteric bud morphogenesis |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0001501 | Biological process | skeletal system development |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0001706 | Biological process | endoderm formation |
GO_0008045 | Biological process | motor neuron axon guidance |
GO_0040036 | Biological process | regulation of fibroblast growth factor receptor signaling pathway |
GO_0062044 | Biological process | negative regulation of cardiac epithelial to mesenchymal transition |
GO_0042474 | Biological process | middle ear morphogenesis |
GO_0021983 | Biological process | pituitary gland development |
GO_0048863 | Biological process | stem cell differentiation |
GO_0048318 | Biological process | axial mesoderm development |
GO_0061626 | Biological process | pharyngeal arch artery morphogenesis |
GO_0060325 | Biological process | face morphogenesis |
GO_0051216 | Biological process | cartilage development |
GO_0021999 | Biological process | neural plate anterior/posterior regionalization |
GO_0007399 | Biological process | nervous system development |
GO_0061037 | Biological process | negative regulation of cartilage development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0005615 | Cellular component | extracellular space |
GO_0098793 | Cellular component | presynapse |
GO_0005576 | Cellular component | extracellular region |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019955 | Molecular function | cytokine binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NOG |
Protein name | Noggin |
Synonyms | |
Description | FUNCTION: Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Essential for cartilage morphogenesis and joint formation. Inhibits chondrocyte differentiation through its interaction with GDF5 and, probably, GDF6 . . |
Accessions | ENST00000332822.6 Q13253 |